HIV-1, HAART and bone metabolism

New Microbiologica

Volumn 25, Issue 3, 2002, Pages 375-384

  Borderi, M ^a   Farneti, B ^a   Tampellini, L ^a   Giuliani, R ^a   Verucchi, G ^a   Vescini, F ^a   Caudarella, R ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone metabolism; HAART; HIV 1

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR;

BONE; BONE DENSITY; BONE REMODELING; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; REVIEW;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE AND BONES; BONE DENSITY; BONE REMODELING; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS;

EID: 0036652048     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. ABU-AMER, Y., and TONDRAVI, M.M. (1997). NF-k B and bone: the breaking point. Nature Medicine, 3, 189-190.
2. AMIEL, C., SLAMA, L., OSTERTAG, A., NGUYEN, T., NAI-IGHIL, L., GHARAKHANIAN, S., LAJEUNIE, E., DE VERNEJOUL, M.C., and ROZENBAUM, W. (2001). Osteoporosis and osteopenia in treated and not treated HIV-positive patients. Antiviral Therapy, 6(4), 25.
3. AUKRUST, P., HAUG, C.J., and UELAND, T. (1999). Deceased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodelling process during highly active antiretroviral therapy. The Journal of Clinical endocrinology and metabolism, 84, 145-150.
4. BARAN, D.T., FAULKNER, K.G., GENENT, H.K., MILLER, P.D., and PACIFICI, R. (1997). Diagnosis and management of osteoporosis: guidelines for utilization of bone densitometry. Calcified Tissue International, 61, 433-440.
5. BELMONTE, M.A., GARCIA-PORTALES, R., DOMENECH, I., FERNANDEZ-NEBRO, A., CAMPUS, M.T., and DE RAMON, E. (1993). Avascular necrosis of bone in human immunodeficiency virus infections and antiphospholipid antibodies. The Journal of rheumatology, 20, 1425-1428.
6. th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, September 2000, Abs. 1304.
7. BLACKSIN, M.F., KLOSER, P.C., and SIMON, J. (1999). Avascular necrosis of bone in human immunodeficiency virus-infected patients. Clinical Imaging, 23, 314-318.
8. BROWN, P.D., and CRANE, L.R. (2001). Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of literature. Clinical Infectious Diseases, 32, 1221-1226.
9. BUCK, B.E., RESNICK, L., SHAH, S.M., and MALININ, T. (1990). HIV cultured from bone. Implications for transplantations. Clinical Orthopaedics and Related Research, 251, 249-253.
10. CARR, A., MILLER, J., and COOPER, D. (2000). Osteopenia in HIV-infected men: association with lactic acidemia and lower weight pre-antiretroviral therapy. Antiviral Therapy, 5(5), 20.
11. CARR, A., MILLER, J., EISMAN, J.A., and COOPER. D.A. (2001). Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS, 15(6). 703-709.
12. th Conference on Retroviruses and Opportunistic infections; Chicago, Illinois, Abs. 630.
13. CHEONIS, N. (2001). Osteoporosis and HIV disease. BETA, 14(2), 26-34.
14. CHEVALIER, X., LARGET-PIET, B., HERNIGOU, P., and GHERARDI, R. (1993). Avascular necrosis of the femoral head in HIV-infected patients. The Journal of bone and joint surgery. British volume, 75, 160.
15. CUMMINGS, S.R., BLACK, D.M., and NEVITT, M.C. (1993) Bone density at various sites for prediction of hip fractures. The study of Osteoporotic Fractures Research Group. Lancet, 341, 72-75.
16. th Annual Meeting of the Infectious Disease Society of America; November 18-21; Philadelphia. Abs. 331.
17. DE TRUCHIS, P., SAILLOUR, M., and PIGNE, E. (1996). Avascular necrosis of bone in HIV-infected patients with antiphospholipid antibodies. XI International Conference on AIDS. Vancouver, Canada. Abs. MoB1298.
18. DUNLOP, M.B., and LANE, N.E. (1999). Osteoporosis: diagnosis, prevention, and treatment of established disease. Bulletin on the rheumatic diseases, 48, 1-4.
19. DUSSO, P., VIDAL, M., POWDERLY, W., YARASHESKY, K.E., and TEBAS, P. (2000). Protease inhibitors inhibit in vitro conversion of 25(OH)-vitamin D to 1,25(OH)2-vitamin D. Antiviral Therapy, 5(5), 19.
20. FALUTZ, J., and ROSENTHAL, L. (2001). Influence of body composition on total body and regional bone mineral content in HIV-infected patients with or without the HIV/highly active antiretroviral therapy-associated lipodystrophy syndrome. Antiviral Therapy, 6(4), 41.
21. ○ International Congress on Drug Therapy in HIV Infection, Glasgow, Abs. P186.
22. GERSTER, J.C., CAMUS, J.P., CHAVE, J.P., KOEGER, A.C., and RAPPOPORT, G. (1991). Multiple site avascular necrosis in HIV infected patients. The Journal of rheumatology, 18, 300-302.
23. GERSTER, J.C., and ROSSETTI, G. (1998). Aseptic avascular osteonecrosis mimicking arthritis on HIV infection. The Journal of rheumatology, 25, 604-605.
24. th Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois, Abs. 478.
25. GLESBY, M., and VAAMONDE, C. (2000). Casecontrol study of avascular necrosis in HIV-infected patients. Antiviral Therapy, 5(5), 21.
26. GOORNEY, B.P., LACEY, H., THURAIRAJASINGAM, S., and BROWN, J.D. (1990). Avascular necrosis of the hip in a man with HIV infection. Genitourinary medicine, 66, 451-2.
27. HAUG, C.J., MULLER, F., AUKRUST, P., and FROLAND, S.S. (1994). Subnormal serum concentration of 1,25-dihydroxyvitamin D3 in HTV infection: correlation with degree of immunodeficiency and survival.. The Journal of infectious diseases, 169, 889-893.
28. HAUG, C.J., MULLER, F., AUKRUST, P., and FROLAND, S.S. (1996). Disseminated Mycobacterium avium complex in AIDS : immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25-dihydroxyvitamin D3. The Journal of infectious diseases. 173, 259-262.
29. HAUG, C.J., AUKRUST, P., HAUG, E., MORKRID, L., MULLER, F., and FROLAND, S.S. (1998). Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. The Journal of Clinical endocrinology and metabolism, 83, 3832-3838.
30. HERMAN, J.S., and EASTERBROOK, P.J. (2001). The metabolic toxicities of antiretroviral therapy. International journal of STD & AIDS, 12(9), 555-62.
31. HERNANDEZ QUERO, J., ORTEGO CENTENO, N., MUNOZ-TORRES, M., MARTINEZ PEREZ, M.A., and TORRES-PUCHOL, J.M. (1993). Alterations in bone turnover in HIV-positive patients. Infection, 21 (4), 220-222.
32. th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, 1999, Abs. 1312.
33. HOY, J., HUDSON, J., LAW, M., and COOPER, D.A. (2000). Osteopenia in a randomized, multicenter study of protease inhibitor (PI) substitution in patients with the lipodystrophy syndrome - extended follow-up to 48 weeks. Antiviral Therapy, 5(5), 42.
34. HUANG, J.S., RIETSCHEL, P., HADIGAN, C.M., ROSENTHAL, D.I., and GRINSPOON, S. (2001). Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodistrophy. AIDS, 15, 975-982.
35. JOHNS, D.G., and GILL, M.J. (1999). Avascular necrosis in HIV infections. AIDS, 13, 1997-1998.
36. KANIS, J.A., DELMAS, P., BURCKHARD, T.P., COOPER, C., and TORGERSON, D. (1994). Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporosis international, 4, 325-331.
37. KANIS, J., JOHNELL, O., and GULLBERG, B. (1999). Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporosis international, 9, 45-54.
38. KERULY, J.C., CHAISSON, R.E., and MOORE, R.D. (2001). Increasing incidence of avascular necrosis of the hip in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 28, 101-102.
39. KNOBEL, H., GUELAR, A., VALLECILLO, G. NOGUES, X., and DIEZ, A. (2001). Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS. 15(6), 807-8.
40. KOEGER, A.C., BANNEVILLE, B., and GERSTER J.C. (1995). Avascular osteonecrosis in HIV-infected patients: 10 cases. Arthritis and rheumatism, 38, S199.
41. th Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois, Abs. 635.
42. LAWAL, A., ENGELSON, E.S., WANG, J., HEYMSFIELD, S.B., and KOTLER, D.P. (2001). Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS, 15(2), 278-280.
43. LILIENFELD, D.E., and KAWABATA, H. (2001). Rate of osteoporosis/aseptic osteonecrosis/hip fracture is the same for users of stavudine and users of zidovudine: a pharmacoepidemiologic investigation of 14000 HIV-positive persons in the MediCal population. Antiviral Therapy, 6(4), 54.
44. LLAUGER, J., PALMER, J., ROSON, N., FERNANDEZ, A., and CAMINS, A. (1998). Osteonecrosis of the knee in an HIV-infected patients., AJR. American journal of roentgenology, 171, 987-988.
45. ○ International Congress on Drug Therapy in HIV Infection, Glasgow, Abs. P187.
46. MAJOR, N.M., and TEHRANZADEH, J. (1997). Musculoskeletal manifestations of AIDS. Radiologic clinics of North America, 35, 1167-1189.
47. th Annual Meeting of the IDSA, 1999, Philadelphia.
48. MANZANEQUE GONZALES, L., MAYORAL MARTIN, L., JIMENEZ OCANA, C., CORZO DELGADO, J.E., SANCHEZ-MATAS Rodriguez, P., Grilo and REINA, A. (1994). Bilateral avascular necrosis of the femur head in an HIV-positive male. Anales de Medicina Interna, 11, 601-603.
49. th Annual Meeting of the IDSA, September 7-10,2000, New Orleans, Louisiana, Abs. 15.
50. MAUSS, S., WEST, T.B., and SCHMUTZ, G. (2001). Assessment of bone density and bone metabolism in long-term HIV-infected individuals with high antiretroviral exposure. Antiviral Therapy, 6(4), 58.
51. MCDERMOTT, A.Y., SHEVITZ, A., KNOX, T., ROUBENOFF, R., KEHAYIAS, J., and GORBACH, S. (2001). Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIVseropositive men and women. The American journal of clinical nutrition, 74(5), 679-86.
52. th Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois. Abs. 628.
53. MELLERT, W., KLEINSCHMIDT, A., SCHMIDT, J., FESTL, H., EMLER, S., ROTH, W.K., and ERFLE, V. (1990). Infection of human fibroblasts and osteoblast-like cells with HIV-1, AIDS, 4(6), 527-35.
54. MEYER, D., BEHRENS, G., SCHMIDT, R.E., and STOLL, M. (1999). Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS, 13, 1147-1148.
55. MOYLE, G.J., NEWEY, C., BALDWIN, C., TORTI, C., MANDALIA, S., and GAZZARD, B.G. (2000). Osteopenia: a consequence of HIV not HAART? Antiviral Therapy, 5(5), 43.
56. MONDY, K., CLAXTON, S., HUFFMAN, M., YARAHESKY, K., POWDERLY, W., and TEBAS, P. (2001). Bone histomorphometry in HIV-infected men. Antiviral Therapy, 6(4), 9.
57. MONIER, P., MCKOWN, K., and BRONZE, M.S. (2001). Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clinical Infectious Diseases, 31, 1488-1492.
58. MOORE, A.L., VASHISHT, A., SABIN, C.A., MOCROFT, A., MADGE, S., PHILLIPS, A.N., STUDD, J.W.W., and JOHNSON, M.A. (2001). Reduced bone mineral density in HIV-positive individuals. AIDS, 15(13), 1731-1733.
59. NEVITT, M.C., JOHNELL, O., BLACK, D.M., ENSRUD, K., GENANT, H.K., and CUMMINGS, S.R. (1994). Bone mineral density predicts non-spine fractures in very elderly women. The Study of Osteoporotic Fractures Research Group. Osteoporosis international, 4, 325-331.
60. NOLAN, D., UPTON, R., JAMES, I., MCKINNON, E., JOHN, M., and MALLAL, S. (2000). Longitudinal analysis of bone mineral density (BMD) in HIV-infected patients treated with HAART: changes in BMD correlate with change in subcutaneous fat; with an additional independent effect of indinavir therapy to increase BMD. Antiviral Therapy, 5(5), 20.
61. NOLAN, D., UPTON, R., MCKINNON, E., JOHN, M., JAMES, I., ADLER, B., ROFF, G., VASIKARAN, S., and MALLAL, S. (2001). Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS, 15, 1275-1280.
62. OLIVE, A., QUERALT, C., SIRERA, G., CENTELLES, M., and FORCE, L. (1998). Osteonecrosis and HIV infection: 4 more cases., The Journal of rheumatology, 25, 1243-1244.
63. PAPIHA, S.S., RATHOD, H., BRICENO, I., POOLEY, J., and DATTA, H.K. (1998) Age-related somatic mitochondrial DNA deletions in bone. Journal of clinical pathology, 51, 117-120.
64. PATON, N.I.J., MACALLAN, D.C., GRIFFIN, G.E., and PAZIANAS, M. (1997). Bone mineral density in patients with human immunodeficiency virus infection. Calcified tissue international, 61, 30-32.
65. RADEMAKER, J., DOBRO, J.S., and SOLOMON, G. (1997). Osteonecrosis and human immunodeficiency virus infection. The Journal of rheumatology. 24, 601-4.
66. ROUDIERE (2000). Osteonecrosis on antiretroviral therapy. Antiviral Therapy, 5(5), 43.
67. Ross, P.D., DAVIS, J.W., EPSTEIN, R.S., and WASNICH, R.D. (1991). Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Annals of internal medicine, 114, 919-923.
68. SCRIBNER, A.N., TROIA-CANCIO, P.V., Cox, B.A., MARCANTONIO, D., HAMID, F., KEISER, P., LEVI, M., ALLEN, B., MURPHY, K., JONES, R.E., and SKIEST, D.J. (2000). Osteonecrosis in HIV: A case-control study. Journal of Acquired Immune Deficiency Syndromes, 25, 19-25.
69. SERRANO, S., MARINOSO, M.L., and SORIANO, J.C. (1995). Bone remodelling in human immunodeficiency virus-1-infection patients. A histomorphometric study. Bone, 16, 185-191.
70. STEPHENS, E.A., DAS, R., MADGE, S., BARTER, J., and JOHNSON, M.A. (1999). Symptomatic osteoporosis in two young HIV-positive African women. AIDS, 13, 2605-2606.
71. TEBAS, P., POWDERLY, W.G., CLAXTON, S., MARIN, D., TANTISIRIWAT, W., TEITELBAUM, S.L., and YARASHESKI, K.E. (2000). Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS, 14, F63-F67.
72. TEBAS, P., YARASHESKI, K., WHYTE, M., CLAXTON, S., DEMARCO, D., and POWDERLY, W. (2000). Serum and urine markers of bone mineral metabolism in HIV infected patients taking protease inhibitor containing potent antiretroviral therapy. Antiviral Therapy, 5(5), 18-19.
73. th Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois, Abs. 633.
74. TIGGES, S., and MELI, R.J. (1995). Osteonecrosis associated with HIV infection. Canadian Association of Radiologists journal. 46, 280-284.
75. th Conference on Retrovirus and Opportunistic Infections. Chicago, Abs. 680.
76. VARANASI, S.S., FRANCIS, R.M., BERGER, C.E., PAPIHA, S.S., and DATTA, H.K. (1999). Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporosis international, 10, 143-149.
77. th Conference on Retroviruses and Opportunistic Infections: Chicago, Illinois, Abs. 541.